FOBT-positive patients who skipped colonoscopy had fourfold higher cancer incidence ...

More than 75 percent of primary care physicians in the United States who order or perform the fecal occult blood test as a screening option for colorectal cancer perform an in-office test rather than ...

April 16, 2010 — Three fourths of primary care physicians order or perform in-office fecal occult blood testing (FOBT), despite national guidelines that support home, not office, collection for FOBT, ...

Background: Current guidelines for screening of colorectal cancer do not offer specific recommendations for cessation of antithrombotic agents prior to fecal occult blood test (FOBT). Aim: To asess ...

TO THE EDITORS:In the July issue of The American Journal of Managed Care, Schroy et al 1 reported on preferences for colorectal cancer (CRC) screening tests in relation to currently recommended ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. After a maximum follow-up of 14 years, the mean ...

Fecal occult-blood testing (FOBT) is a noninvasive, effective means of screening for colorectal cancer (CRC). The SENSITIVITY of this technique is suboptimal, however, and identification of a simple, ...

Nothing elicits a groan from patients as quickly as discussion of uncomfortable screening procedures. Yet those discussions must take place. Colorectal cancer is the third-most common cancer in the ...

Bottom Line: A multipart intervention increased adherence rates of annual fecal occult blood testing (FOBT) for colorectal cancer (CRC) screening in vulnerable populations. Author: David W. Baker, M.D ...

To best detect the presence of colorectal cancer, patients must undergo a colonoscopy – an invasive procedure that examines the rectum and entire colon. However, the exam is only performed once every ...

Objective: To assess patient preferences for 1 of the recommended colorectal cancer screening options or stool DNA testing (sDNA), a novel noninvasive screening test. Study Design: Cross-sectional ...